Baijin Life Science Holdings Limited (HKG:1466)
1.140
+0.020 (1.79%)
Jul 10, 2026, 3:45 PM HKT
HKG:1466 Balance Sheet
Financials in millions HKD. Fiscal year is April - March.
Millions HKD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 43.11 | 47.77 | 37.88 | 41.26 | 23.59 |
Short-Term Investments | 0.93 | 0.8 | 0.71 | 0.59 | 0.59 |
Cash & Short-Term Investments | 44.04 | 48.57 | 38.59 | 41.85 | 24.17 |
Cash Growth | -9.33% | 25.85% | -7.78% | 73.13% | -3.17% |
Accounts Receivable | 15.05 | 25.93 | 15.89 | 7.02 | 5.67 |
Other Receivables | 44.62 | 71.12 | 14.34 | 0.42 | 20.9 |
Receivables | 59.67 | 97.05 | 30.23 | 7.44 | 26.56 |
Inventory | 58.28 | 70.64 | 44.34 | 44.61 | 23.98 |
Prepaid Expenses | 30.1 | 10.74 | 8.16 | 4.98 | 4.84 |
Total Current Assets | 192.09 | 227 | 121.32 | 98.87 | 79.56 |
Property, Plant & Equipment | 30.74 | 16.84 | 8.78 | 0.98 | 2.55 |
Long-Term Investments | 1.11 | - | - | - | - |
Goodwill | 15.36 | 28.36 | 48.36 | - | - |
Other Intangible Assets | 4.59 | 5.91 | 7.35 | - | - |
Long-Term Deferred Tax Assets | 1.09 | 0.94 | 0.04 | - | - |
Other Long-Term Assets | 19.46 | 11.13 | 10.95 | - | - |
Total Assets | 264.44 | 290.17 | 196.8 | 99.85 | 82.11 |
Accounts Payable | 10.13 | 8.34 | 7.87 | 9.01 | 4.6 |
Accrued Expenses | 8.92 | 7.04 | 4.15 | 0.44 | 1.45 |
Short-Term Debt | 13.68 | 12.56 | 9.42 | 2 | 29.78 |
Current Portion of Leases | 9.23 | 5.08 | 1.11 | 0.76 | 1.28 |
Current Income Taxes Payable | 0.48 | 1.28 | 1.53 | - | - |
Current Unearned Revenue | 3.27 | 3.04 | 4.75 | - | - |
Other Current Liabilities | 18.91 | 12.38 | 12.16 | 8.87 | 8.36 |
Total Current Liabilities | 64.63 | 49.72 | 40.99 | 21.08 | 45.46 |
Long-Term Debt | - | 75.28 | 39.71 | - | - |
Long-Term Leases | 5.5 | 7.01 | 0.95 | - | 0.78 |
Pension & Post-Retirement Benefits | 0.91 | 0.77 | 0.47 | 0.49 | - |
Long-Term Deferred Tax Liabilities | 1.15 | 1.51 | 1.89 | - | - |
Total Liabilities | 72.18 | 134.3 | 84.01 | 21.56 | 46.24 |
Common Stock | 18.65 | 15.45 | 13.59 | 12.79 | 6.39 |
Additional Paid-In Capital | - | 688.54 | 645.9 | 619.13 | 592.75 |
Retained Earnings | - | -559.94 | -559.5 | -560.81 | -569.48 |
Comprehensive Income & Other | 166.55 | -4.76 | -3.67 | 7.18 | 6.21 |
Total Common Equity | 185.19 | 139.28 | 96.31 | 78.29 | 35.87 |
Minority Interest | 7.06 | 16.59 | 16.48 | - | - |
Shareholders' Equity | 192.25 | 155.88 | 112.79 | 78.29 | 35.87 |
Total Liabilities & Equity | 264.44 | 290.17 | 196.8 | 99.85 | 82.11 |
Total Debt | 28.41 | 99.93 | 51.19 | 2.76 | 31.84 |
Net Cash (Debt) | 15.63 | -51.36 | -12.6 | 39.09 | -7.67 |
Net Cash Per Share | 0.02 | -0.07 | -0.02 | 0.06 | -0.02 |
Filing Date Shares Outstanding | 932.25 | 772.39 | 679.25 | 639.3 | 319.65 |
Total Common Shares Outstanding | 932.25 | 772.39 | 679.25 | 639.3 | 319.65 |
Working Capital | 127.46 | 177.28 | 80.33 | 77.8 | 34.09 |
Book Value Per Share | 0.20 | 0.18 | 0.14 | 0.12 | 0.11 |
Tangible Book Value | 165.24 | 105.01 | 40.6 | 78.29 | 35.87 |
Tangible Book Value Per Share | 0.18 | 0.14 | 0.06 | 0.12 | 0.11 |
Machinery | - | 8.77 | 28.8 | 23.37 | 23.34 |
Leasehold Improvements | - | 3.93 | 2.22 | 0.54 | 0.54 |